Cargando…

In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation

Literature reported that nsp3 of CHIKV is an important target for the designing of drug as it involves in the replication, survival etc. Herein, about eighteen million molecules available in the ZINC database are filtered against nsp3 using RASPD. Top five hit drug molecules were then taken from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Durgesh, Meena, Mahendra Kumar, Kumari, Kamlesh, Patel, Rajan, Jayaraj, Abhilash, Singh, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452467/
https://www.ncbi.nlm.nih.gov/pubmed/32904235
http://dx.doi.org/10.1016/j.heliyon.2020.e04720
_version_ 1783575166977048576
author Kumar, Durgesh
Meena, Mahendra Kumar
Kumari, Kamlesh
Patel, Rajan
Jayaraj, Abhilash
Singh, Prashant
author_facet Kumar, Durgesh
Meena, Mahendra Kumar
Kumari, Kamlesh
Patel, Rajan
Jayaraj, Abhilash
Singh, Prashant
author_sort Kumar, Durgesh
collection PubMed
description Literature reported that nsp3 of CHIKV is an important target for the designing of drug as it involves in the replication, survival etc. Herein, about eighteen million molecules available in the ZINC database are filtered against nsp3 using RASPD. Top five hit drug molecules were then taken from the total screened molecules (6988) from ZINC database. Then, a one pot-three components reaction is designed to get the pyrazolophthalazine and its formation was studied using DFT method. Authors created a library of 200 compounds using the product obtained in the reaction and filtered against nsp3 of CHIKV based on docking using iGEMDOCK, a computational tool. Authors have studied the best molecules after applying the the Lipinski's rule of five and bioactive score. Further, the authors took the best compound i.e. CMPD178 and performed the MD simulations and tdMD simulations with nsp3 protease using AMBER18. MD trajectories were studied to collect the information about the nsp3 of CHIKV with and without screened compound and then, MM-GBSA calculations were performed to calculate change in binding free energies for the formation of complex. The aim of the work is to find the potential candidate as promising inhibitor against nsp3 of CHIKV.
format Online
Article
Text
id pubmed-7452467
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74524672020-09-04 In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation Kumar, Durgesh Meena, Mahendra Kumar Kumari, Kamlesh Patel, Rajan Jayaraj, Abhilash Singh, Prashant Heliyon Article Literature reported that nsp3 of CHIKV is an important target for the designing of drug as it involves in the replication, survival etc. Herein, about eighteen million molecules available in the ZINC database are filtered against nsp3 using RASPD. Top five hit drug molecules were then taken from the total screened molecules (6988) from ZINC database. Then, a one pot-three components reaction is designed to get the pyrazolophthalazine and its formation was studied using DFT method. Authors created a library of 200 compounds using the product obtained in the reaction and filtered against nsp3 of CHIKV based on docking using iGEMDOCK, a computational tool. Authors have studied the best molecules after applying the the Lipinski's rule of five and bioactive score. Further, the authors took the best compound i.e. CMPD178 and performed the MD simulations and tdMD simulations with nsp3 protease using AMBER18. MD trajectories were studied to collect the information about the nsp3 of CHIKV with and without screened compound and then, MM-GBSA calculations were performed to calculate change in binding free energies for the formation of complex. The aim of the work is to find the potential candidate as promising inhibitor against nsp3 of CHIKV. Elsevier 2020-08-24 /pmc/articles/PMC7452467/ /pubmed/32904235 http://dx.doi.org/10.1016/j.heliyon.2020.e04720 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kumar, Durgesh
Meena, Mahendra Kumar
Kumari, Kamlesh
Patel, Rajan
Jayaraj, Abhilash
Singh, Prashant
In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
title In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
title_full In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
title_fullStr In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
title_full_unstemmed In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
title_short In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
title_sort in-silico prediction of novel drug-target complex of nsp3 of chikv through molecular dynamic simulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452467/
https://www.ncbi.nlm.nih.gov/pubmed/32904235
http://dx.doi.org/10.1016/j.heliyon.2020.e04720
work_keys_str_mv AT kumardurgesh insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation
AT meenamahendrakumar insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation
AT kumarikamlesh insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation
AT patelrajan insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation
AT jayarajabhilash insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation
AT singhprashant insilicopredictionofnoveldrugtargetcomplexofnsp3ofchikvthroughmoleculardynamicsimulation